# Metabolic Effects of Switching Kaletra to Boosted Reyataz

> **NCT00413153** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 15 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** atazanavir/ritonavir
- **DRUG:** lopinavir/ritonavir

## Key facts

- **NCT ID:** NCT00413153
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2010-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00413153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00413153, "Metabolic Effects of Switching Kaletra to Boosted Reyataz". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00413153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*